| Literature DB >> 32460819 |
Weiming Wang1, Shuting Wang2, Wujian Lin1, Xian Li1, Lars L Andersen3, Yuling Wang4.
Abstract
BACKGROUND: Whole body vibration (WBV) is currently increasing in popularity as a treatment modality for musculoskeletal disorders and improving health-related quality of life. Recent research has shown that WBV can reduce low back pain and improve the functional abilities for patients, however, optimal frequency and duration of vibration for therapeutic use is unclear. This review was conducted to summarize and determine the efficacy of whole body vibration therapy on individuals with non-specific low back pain (NLBP) and evaluated methodological quality of the included studies.Entities:
Keywords: Low back pain; Physical therapy modalities; Vibration
Year: 2020 PMID: 32460819 PMCID: PMC7251707 DOI: 10.1186/s12906-020-02948-x
Source DB: PubMed Journal: BMC Complement Med Ther ISSN: 2662-7671
Fig. 1Flowchart of the literature search
Level of evidence for the included studies
| Clinical trail | Items on the PEDro scale | Total score | Level of quality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |||
| 1. Ruan et al. (2008) [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | Fair |
| 2. Pozo-Cruz et al. (2011) [ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 | Good |
| 3. Rittweger et al. (2002) [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | Fair |
| 4. Yang et al. (2015) [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 | Fair |
| 5. Kaeding et al. (2017) [ | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | Good |
| 6. Wegener et al. (2019) [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | Fair |
| 7. Wang et al. (2019) [ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
0: criterion not fulfilled; 1: criterion fulfilled
The items are listed as follows: 1: eligibility criteria were specified; 2: subjects were randomly allocated to groups or to a treatment order; 3: allocation was concealed; 4: the groups were similar at baseline; 5: there was blinding of all subjects; 6: there was blinding of all therapists; 7: there was blinding of all assessors; 8: measures of at least one key outcome were obtained from more than 85% of the subjects who were initially allocated to groups; 9: intention-to- treat analysis was performed on all subjects who received the treatment or control condition as allocated; 10: the results of between-group statistical comparisons are reported for at least one key outcome; 11: the study provides both point measures and measures of variability for at least one key outcome;
Total score: each satisfied item (except the first) contributes 1 point to the total score, yielding a PEDro scale score that can range from 0 to 10
Level of evidence: 6–8 of “good” quality, 4–5 of “fair” quality, and below 4 of “poor” quality
Description of the included studies
| Study | Population | Intervention and comparison | Outcome Measures [Timing] |
|---|---|---|---|
| 1. Ruan et al. (2008) [ | 94 postmenopausal women with osteoporosis | WBV group: 5 times per week, 10 min each time and totally for 6 months; Equipment = ZD-10 vibration therapeutic apparatus | Visual analogue scale |
| Age&(years) = WBV 61.23 (8.20); comparison 63.73 (5.45) | Control group: without any treatment | [0, 3, 6 months] | |
| BMI&(kg/m2) = WBV 24.37 (3.28); comparison 23.22 (3.25) | |||
| Baseline pain intensity& (/10) a = WBV 3.21 (2.36); comparison 3.11 (2.29) | |||
| 2. Pozo-Cruz et al. (2011) [ | Fifty female and male patients with NCLBP | WBV group: standing on the platform with their feet side by side and knee at 120°. Training was performed twice a week for 12 weeks, with at least 1 day of rest between any 2 consecutive sessions; Equipment = Galileo 2000 | Visual analogue scale (100 points) |
| Age&(years) = WBV 58.71 (4.59); comparison 59.53 (5.47) | Control group: continue with their normal pattern of daily activity for the 12-week duration | The Roland Morris Questionnaire and the Oswestry Disability Index | |
| BMI&(kg/m2) = WBV 28.6 (3.84); comparison 31.47 (6.41) | [0, 12 weeks] | ||
| Baseline pain intensity& (/100) a = WBV 38.36 (15.85); comparison 39.54 (13.26) | |||
| 3. Yang et al. (2015) [ | 19 female and 21 male patients with LBP working in a business | WBV group: 25 min of lumbar stability training and 5 min of WBV. Patient was positioned with slight flexion of the knee joints and lumbar lordosis stood on the platform device; Equipment = Galileo 2000 | Visual analogue scale |
| Age& (years) = WBV 32.80; comparison 30.95 | Control group: 30 min of lumbar stability training | Oswestry disability index (Korean) | |
| BMI&(kg/m2) = WBV 24.37; comparison 23.33 | (Both group received training three times per week for a total of 6 weeks) | [0, 6 weeks] | |
| Baseline pain intensity& (/10) a = WBV 5.60 (1.60); comparison 5.25 (1.12) | |||
| Baseline disability& (/100%)o = WBV 17.85 (11.09); comparison 15.30 (7.57) | |||
| 4. Rittweger et al. (2002) [ | 60 female and male patients with CLBP | WBV group: Subject performed slow bending and rotation of their hips and waists; 4 min of duration for each exercise unit; Equipment = Galileo 2000 | Visual analogue scale |
| Age&(years) = WBV 54.1 (3.4); comparison 49.8 (6.6) | Control group: performing repetitive isodynamic lumbar extension exercise | Pain disability index (PDI) | |
| BMI&(kg/m2) = WBV 24.9 (2.3); comparison 27.5 (7.3) | (Both groups performed the exercise training for 12 weeks) | [0, 12–24 weeks] | |
| Baseline pain intensity& (/10) a = WBV 4.2 (1.9); comparison 4.5 (2.2) | |||
| Baseline disability& (/70) p = WBV 20.3 (9.9); comparison 20.7 (14.3) | |||
| 5. Kaeding et al. (2017) [ | 28 female and 13 male patients with CLBP | WBV group: 2.5 times per week, 15 min each time and totally for 3 months; Patient was positioned with legs slightly bent, holding a slightly lordotic back, abdominal muscle contracted, hands on the hand rails and head held erect; Equipment = Galileo Fit | The Roland Morris Questionnaire and the Oswestry Disability Index |
| Age&(years) = WBV 46.4 (9.3); comparison 44.6 (9.1) | Control group: continue with their usual activities for the 3-month duration | [0, 12 weeks] | |
| BMI&(kg/m2) = WBV 25.5 (4.2); comparison 27.8 (6.0) | |||
| Baseline disability& (/24) r = WBV 4.0 (3.8); comparison 3.5 (2.3) | |||
| 6. Wegener et al. (2019) [ | 45 female and 20 male participants with chronic back pain (only 44 recruited in the study) | WBV group: performed WBV therapy guided by a physiotherapist twice a week for 3 blocks of 6 weeks on a plate, increasing time and intensity at each block; Equipment = Galileo (Novotec Medical GmbH, Pforzheim, Germany) | NASS-LS lumbar pain subscale |
| Age&(years) = 61.6 (7.9) | Control group: performed active classic physiotherapy under the guidance of a physiotherapist twice a week for 3 blocks of 6 weeks | Oswestry Disability Index | |
| Baseline lumbar pain& (/6) n = WBV 2.6 (0.6); comparison 2.9 (0.5) | (Both groups performed the repetitions of 5 defined trunk stability exercises for 18 weeks) | [0, 18–24 weeks] | |
| Baseline disability& (/100%)o = WBV 18.1 (12.0); comparison 20.7 (11.4) | |||
| 7. Wang et al. (2019) [ | 24 female and 65 male with CLBP | WBV group: performed the whole-body vibration exercises with an available vibratory machine; Equipment = VIB5070; BODYGREEN, Taiwan, China | Visual analogue scale |
| Age&(years) = WBV 21.64 (3.01); comparison 22.02 (4.59) | Control group: received general exercise protocol | Oswestry Disability Index | |
| BMI&(kg/m2) = WBV 22.68 (2.54); comparison 21.88 (1.88) | (Each session in both group included 5-min warm-up, 15-min general exercise and 5-min cool down. The exercise protocols in control group were similar to those of the WBV group but without vibratory stimulation) | [0, 12 weeks] | |
| Baseline pain intensity& (/10) a = WBV 4.44 (1.14); comparison 4.00 (1.34) | |||
| Baseline disability& (/100%)o = WBV 32.67 (10.41); comparison 31.97 (8.7) |
&values represent Mean [Standard Deviation]
aas measured by Visual Analog Scale
bas measured by Face scale (11 point)
oas measured by Oswestry Disability Index
ras measured by Roland Morris Disability Questionnaire
pas measured by Pain disability index
nas measured by NASS-LS lumbar pain subscale
Whole body vibration parameters and prescriptions
| Authors | Frequency (Hz) | Amplitude (mm) | Vibration device | Type of vibration | Duration (weeks) | Number of sessions | Number of series | Time series (min) |
|---|---|---|---|---|---|---|---|---|
| 1. Ruan et al. (2008) [ | 30 | 5 | ZD-10 vibration therapeutic apparatus | NR | 24 | 120 | 1 | 10 |
| 2. Pozo-Cruz et al. (2011) [ | 20 | NR | Galileo 2000 | Side-alternating oscillations | 12 | 24 | 1 | NR |
| 3. Rittweger et al. (2002) [ | 18 | 6 | Galileo 2000 | NR | 12 | 12 in the 1st session; 6 in the 2nd session | 4 in the beginning then increased to 7 | NR |
| 4. Yang et al. (2015) [ | 1–50 | Controlled without restriction | Galileo 2000 | NR | 6 | 18 | 1 | 3 |
| 5. Kaeding et al. (2017) [ | 10–30 | 1.5–3.5 | Galileo 2000 | Sinusoidal vibration | 12 | 30 | 5 | 1–2 |
| 6. Wegener et al. (2019) [ | 5–12 12–20 20 | NR | Galileo plate (Novotec Medical GmbH, Pforzheim, Germany) | NR | 18 | 36 | 5 | 1 1.5 2 |
| 7. Wang et al. (2019) [ | 18 | NR | VIB5070; BODYGREEN, Taiwan, China | NR | 12 | 36 | 5 | 2–3 |
NR not reported
Outcome measures
| Authors | Instrument | Outcome measure | CG baseline | CG after treatment | EG baseline | EG after treatment | Treatment effect | Reported effect |
|---|---|---|---|---|---|---|---|---|
| 1. Ruan et al. (2008) [24] | Dual-energy bone densitometers | Lumbar BMD | 0.760 ± 0.053 | 0.755 ± 0.033 | 0.836 ± 0.022 | 0.847 ± 0.021 | Δ | |
| 0.746 ± 0.035 | 0.872 ± 0.024 | Δ# | ||||||
| Femoral neck BMD | 0.583 ± 0.095 | 0.575 ± 0.089 | 0.666 ± 0.100 | 0.069 ± 0.103 | = | |||
| 0.573 ± 0.099 | 0.687 ± 0.106 | Δ# | ||||||
| Visual analogue scale | Chronic back pain | 3.11 ± 2.29 | 3.25 ± 2.18 | 3.21 ± 2.36 | 1.78 ± 2.05 | Δ↑ | ||
| 3.50 ± 2.12 | 1.35 ± 1.92 | Δ↑ | ||||||
| 2. Pozo-Cruz et al. (2011) [25] | The Roland Morris Questionnaire | NCLBP- associated disability | 12.44 ± 4.46 | 12.40 ± 4.50 | 11.63 ± 8.35 | 10. 47 ± 8.68 | −1.12 | Δ↑ |
| Oswestry Disability Index (%) | 29.16 ± 15.78 | 29.24 ± 15.64 | 26.50 ± 17.00 | 20.28 ± 10.89 | −6.3 | Δ↑ | ||
| EuroQol 5D-3 L | HRQoL (tto) | 0.69 ± 0.03 | 0.68 ± 0.18 | 0.71 ± 0.05 | 0.76 ± 0.23 | 0.06 | Δ↑ | |
| VAS back (0–100 points) | Pain | 39.54 ± 13.26 | 39.68 ± 14.77 | 38.36 ± 15.85 | 29.00 ± 13.02 | −9.40 | Δ↑ | |
| 3. Rittweger et al. (2002) [26] | Visual analog scale | Pain Sensation | 4.52 ± 1.7 | 1.20 ± 1.76 | 4.16 ± 1.86 | 1.40 ± 1.83 | Δ# | |
| Pain disability index | Pain-Related Limitation | 20.3 ± 9.9 | 10.5 ± 12.8 | 20.7 ± 14.3 | 11.6 ± 11.1 | Δ# | ||
| 12.0 ± 12.4 | 14.8 ± 13.6 | Δ# | ||||||
| 4. Yang et al. (2015) [27] | Tetrax | Fall index | 23.40 ± 12.73 | 21.69 ± 12.68 | 30.59 ± 14.97 | 12.80 ± 10.39 | Δ↑ | |
| Korean Oswestry disability index | Disability index | 15.30 ± 7.57 | 12.80 ± 5.67 | 17.85 ± 11.09 | 12.45 ± 6.06 | Δ# | ||
| 100 mm visual analogue scale | Pain | 5.25 ± 1.12 | 3.50 ± 0.76 | 5.60 ± 1.60 | 2.70 ± 1.26 | Δ#↑ | ||
| 5. Kaeding et al. (2017) [28] | The Roland Morris Questionnaire | Disability index | 3.5 ± 2.3 | 4.0 ± 2.4 | 4.0 ± 3.8 | 2.3 ± 2.9 | Δ↑* | |
| Oswestry Disability Index | Disability index | 15.7 ± 7.1 | 17.3 ± 6.8 | 17.2 ± 9.2 | 12.3 ± 7.4 | Δ↑ | ||
| SF-36 (physical) | Quality of life | 47.5 ± 4.2 | 43.8 ± 9.3 | 45.0 ± 8.6 | 48.1 ± 8.0 | Δ↑ | ||
| 6. Wegener et al. (2019) [29] | NASS-LS lumbar pain subscale | Pain | 2.9 ± 0.5 | 2.5 ± 0.8 | 2.6 ± 0.6 | 2.6 ± 0.7 | = | |
| Oswestry Disability Index | NCLBP- associated | 20.7 ± 11.4 | 16.6 ± 12.3 | 18.1 ± 12.0 | 17.1 ± 11.9 | = | ||
| SF-36 physical summary | disability Quality of life | 39.5 ± 9.1 | 41.4 ± 8.3 | 37.9 ± 7.5 | 40.7 ± 8.2 | = | ||
| 7. Wang et al. (2019) [30] | Visual analogue scale | Pain | 4.05 (3.83, 4.29) | 3.87 (3.53, 4.21) | 4.39 (4.16, 4.61) | 2.87 (2.53, 3.21) | −1 | Δ ↑ |
| Oswestry Disability Index | Functional disability | 32.18 (29.91, 34.5) | 23.27 (21.47, 25.07) | 32.46 (30.22, 34.71) | 19.46 (17.69, 21.24) | −3.81 | Δ ↑ | |
| SF-36 (physical functioning) | Quality of life | 77.81 (75.79, 79.83) | 81.39 (79.21, 83.57) | 75 (73.03, 77.02) | 83.3 (81.15, 85.45) | 1.91 | Δ ↑ |
Values are recorded as mean (SD) or mean (95% CI)
=:no significant difference relative to baseline and/or the control group
↑: statistically significant improvement in the WBV group relative to the control group
Δ: statistically significant improvement in the WBV group relative to baseline
#: statistically significant improvement in the control group relative to baseline
*Intention-to-treat analysis